Immune-mediated antitumor effect by type 2 diabetes drug, metformin
Okayama University · Kawasaki University of Medical Welfare
Abstract
Significance The multifunctional ability of CTLs is downregulated by interaction between immune-checkpoint molecules expressed on CTLs and their ligands expressed on cancer cells, referred to as immune exhaustion. The antibody-mediated, immune-checkpoint blockade turned out to a promising method for immunotherapy against advanced melanoma. Metformin, a drug prescribed for patients with type 2 diabetes, has been recognized to have anti-cancer effect. We found that CD8 + tumor infiltrating lymphocytes (TILs) is a target of metformin. CD8 + TILs inevitably undergo immune exhaustion, characterized by diminished production of multiple cytokines such as IL-2, TNFα, and IFNγ, followed by elimination with apoptosis.…
Citation impact
- FWCI
- 20.63
- Percentile
- 100%
- References
- 47
Authors
6Topics & keywords
- Metformin
- Type 2 diabetes
- Drug
- Immune system
- Medicine
- Diabetes mellitus
- Pharmacology
- Internal medicine
- Good health and well-being